About Matthew B. Sullivan of CONTRAVISORY

Matthew B. Sullivan is Chief Compliance Officer at Contravisory Research & Mgmt and has been affiliated with Contravisory Research & Mgmt since January-2008.

Contravisory Research & Mgmt is a hedge fund that manages 677.9 MM dollars in regulatory AUM and has 7 employees, of which 5 perform investment advisory functions. The managers's latest filing has disclosed 408MM in positions, which represents 60% of the manager's regulatory AUM.

For more on Contravisory Research & Mgmt including top positions, information on the investment process, service provider information, other key employees, real time performance, 13-F holdings and more visit the Fund Profile

CONTRAVISORY StockAlpha

-0.8%
Top 25%
StockAlpha 3 yr performance attributed to stock picking: -0.8%/yr

Co-workers of Matthew B. Sullivan at CONTRAVISORY

Name Title In Position Since
William M. Noonan President/Ceo July-2006
Philip A. Noonan Chief Operating Officer July-2006

Fundamental & Technical Factor Exposure

Market Cap Beta Volatility
Momentum (12M) Momentum (6M) Momentum (3M)
Price/Book Price/Earnings Price/Cash Flow
Dividend Yield Sales Growth Earnings Growth
ROE ROA ROC
EBIDTA Margin Debt/Assets Hedge Fund Crowding
Symmetric Rankings
Have Been Featured In

Matthew B. Sullivan Office Address

120 LONGWATER DRIVE
SUITE 100
NORWELL, Massachusetts
UNITED STATES, 02061

Matthew B. Sullivan Contact Information

Phone Number: 781-740-1786
Fax Number: 781-749-4910
Website:

READ RECENT SYMMETRIC REPORTS

Disclaimer

The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here